APA

Boegemann M., Khaksar S., Bera G., Birtle A., Dopchie C., Dourthe L., Everaert E., Hatzinger M., Hercher D., Hilgers W., Matus G., Alvarez L. G., Antoni L., Lukac M., Pissart G., Robinson P. & Elliott T. (20190423). Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study. : BMC cancer.

Chicago

Boegemann Martin, Khaksar Sara, Bera Guillaume, Birtle Alison, Dopchie Catherine, Dourthe Louis-Marie, Everaert Els, Hatzinger Martin, Hercher Dirko, Hilgers Werner, Matus Geoffrey, Alvarez Laura Garcia, Antoni Laurent, Lukac Martin, Pissart Geneviève, Robinson Paul and Elliott Tony. 20190423. Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study. : BMC cancer.

Harvard

Boegemann M., Khaksar S., Bera G., Birtle A., Dopchie C., Dourthe L., Everaert E., Hatzinger M., Hercher D., Hilgers W., Matus G., Alvarez L. G., Antoni L., Lukac M., Pissart G., Robinson P. and Elliott T. (20190423). Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study. : BMC cancer.

MLA

Boegemann Martin, Khaksar Sara, Bera Guillaume, Birtle Alison, Dopchie Catherine, Dourthe Louis-Marie, Everaert Els, Hatzinger Martin, Hercher Dirko, Hilgers Werner, Matus Geoffrey, Alvarez Laura Garcia, Antoni Laurent, Lukac Martin, Pissart Geneviève, Robinson Paul and Elliott Tony. Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study. : BMC cancer. 20190423.